![Hiromi Watanabe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiromi Watanabe
Director/Board Member at
KYORIN PHARMACEUTICAL CO., LTD.
Profile
Hiromi Watanabe is associated with two current jobs.
He is an Independent Outside Director at KYORIN Pharmaceutical Co., Ltd. since 2019 and a Director at 311 Children's Fund for Thyroid Cancer in Japan since 2018.
Hiromi Watanabe active positions
| Companies | Position | Start |
|---|---|---|
| KYORIN PHARMACEUTICAL CO., LTD. | Director/Board Member | 2019-05-31 |
311Children's Fund for Thyroid Cancer in Japan | Director/Board Member | 2018-05-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
KYORIN Pharmaceutical Co., Ltd.
 KYORIN Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals through its subsidiaries | Health Technology |
311Children's Fund for Thyroid Cancer in Japan |
- Stock Market
- Insiders
- Hiromi Watanabe
